Alg ribavirin kombinationsbehandling og zidovudin kan have øget risiko for at udvikle anæmi.
Patients treated with Viraferon and ribavirin combination therapy and zidovudine could be at increased risk of developing anaemia.
Tand- og tandkødslidelser, som kan lede til tab af tænder,er blevet rapporteret hos patienter, der fik IntronA og ribavirin kombinationsbehandling.
Dental and gum disorders, which may lead to loss of teeth,have been reported in patients receiving IntronA and ribavirin combination therapy.
Patienter behandlet med IntronA og ribavirin kombinationsbehandling og zidovudin kan have øget risiko for at udvikle anæmi.
Patients treated with IntronA and ribavirin combination therapy and zidovudine could be at increased risk of developing anaemia.
Dentale og parodontale lidelser, som kan føre til tab af tænder,er blevet rapporteret hos patienter, der fik IntronA og ribavirin kombinationsbehandling.
Dental and periodontal disorders, which may lead to loss of teeth,have been reported in patients receiving IntronA and ribavirin combination therapy.
Patienter behandlet med IntronA og ribavirin kombinationsbehandling og zidovudin kan herudover have en øget risiko for at udvikle anæmi lavt antal røde blodceller.
Additionally, patients treated with IntronA and ribavirin combination therapy and zidovudine could be at increased risk of developing anaemia low number of red blood cells.
Patienter med disse tilstande, som ikke effektivt kan kontrolleres med medicinering, bør ikke påbegynde hverken Pegasys monoterapi eller Pegasys/ ribavirin kombinationsbehandling.
Patients with these conditions who cannot be effectively controlled by medication should not begin Pegasys monotherapy nor Pegasys/ ribavirin combination therapy.
Patienter behandlet med ViraferonPeg og ribavirin kombinationsbehandling og zidovudin kan herudover have øget risiko for udvikling af anæmi lavt antal røde blodceller.
Additionally, patients treated with ViraferonPeg and ribavirin combination therapy and zidovudine could be at increased r isk of developing anaemia low number of red blood cells.
Denne kombination er også indiceret til patienter med tilbagefald og patienter,der ikke tidligere har responderet på interferon alfa(pegyleret eller non- pegyleret) og ribavirin kombinationsbehandling eller interferon alfa monoterapi.
This combination is also indicated in relapse patients andpatients who have not responded previously to interferon alpha(pegylated or nonpegylated) and ribavirin combination therapy or interferon alpha monotherapy.
Det virologiske respons for patienter behandlet med Pegasys monoterapi og med Pegasys og ribavirin kombinationsbehandling i relation til genotype og viral belastning ved baseline for hiv- HCV- co- inficerede patienter er angivet i tabel 14.
HIV-HCV co-infected patients The virological responses of patients treated with Pegasys monotherapy and with Pegasys and ribavirin combination therapy in relation to genotype and pre-treatment viral load for HIV-HCV co- infected patients are summarised below in Table 14.
Patienter, som opnåede ikke- detekterbare niveauer af HCV- RNA efter 20 ugers behandling, fortsatte i Pegasys plus ribavirin kombinationsbehandling i sammenlagt 48 uger og blev siden fulgt i 24 uger efter afsluttet behandling.
Patients who achieved undetectable levels of HCV RNA after 20 weeks of treatment remained on Pegasys plus ribavirin combination therapy for a total of 48 weeks and were then followed for 24 weeks after the end of treatment.
Alvorlig CNS- påvirkning, særligt depression,selvmordstanker og selvmordsforsøg, er set hos nogle patienter under Ribavirin- kombinationsbehandling med peginterferon alfa- 2b eller interferon alfa- 2b, og selv efter behandlingsophør især under 6- måneders opfølgningsperioden.
Severe CNS effects, particularly depression, suicidal ideation andattempted suicide have been observed in some patients during Ribavirin combination therapy with peginterferon alfa-2b or interferon alfa-2b, and even after treatment discontinuation mainly during the 6-month follow-up period.
Rebetol kan i kombination med peginterferon alfa- 2b ydermere anvendes i behandlingen af voksne patienter med kronisk hepatitis C, der tidligere har haft tilbagefald efter at have fulgt behandling med alfa interferon(pegyleret eller non- pegyleret) og ribavirin kombinationsbehandling, eller som ikke har reageret på tidligere behandling med alfa interferon(pegyleret eller non- pegyleret) og ribavirin kombinationsbehandling eller alfa interferon monoterapi.
Additionally, Rebetol in combination with peginterferon alfa-2b can be used for the treatment of adult patients with chronic hepatitis C who have previously relapsed following treatment with alpha interferon(pegylated or nonpegylated) and ribavirin combination therapy, or have not responded to previous treatment with alpha interferon(pegylated or nonpegylated) and ribavirin combination therapy or alpha interferon monotherapy.
Bivirkninger rapporteret med Pegasys- monoterapi hos patienter med HBV eller HCV eller hos HCV- patienter i kombinationsbehandling med ribavirin System- organklasse.
Undesirable Effects Reported with Pegasys Monotherapy for HBV or HCV or In Combination with Ribavirin for HCV Patients Body system.
Vedvarende virologisk respons baseret på hurtig virologisk respons ved uge 4 for genotype 1 og 4 efter Pegasys kombinationsbehandling med ribavirin hos HCV- patienter.
Sustained Virological Response Based on Rapid Viral Response at week 4 for Genotype 1 and 4 after Pegasys Combination Therapy with Ribavirin in HCV Patients.
Kombinationsbehandling med Ribavirin og interferon alfa- 2b resulterede i et vedvarende virologisk respons, der var ti gange større end ved interferon alfa- 2b alene 49% mod 5%, p< 0, 0001.
Combination therapy with Ribavirin and interferon alfa-2b resulted in a sustained virological response that was ten-fold higher than that with interferon alfa-2b alone 49% vs 5%, p< 0.0001.
Brugen af Pegasys og ribavirin i kombinationsbehandling hos kroniske hepatitis C- patienter, hvor tidligere behandling har svigtet, er ikke blevet undersøgt tilstrækkelig hos patienter, som har afbrudt tidligere behandling på grund af hæmatologiske uønskede hændelser.
The use of Pegasys and ribavirin combination therapy in chronic hepatitis C patients who failed prior treatment has not been adequately studied in patients who discontinued prior therapy for hematological adverse events.
Brugen af Pegasys og ribavirin i kombinationsbehandling hos kroniske hepatitis C- patienter, hvor tidligere behandling har svigtet, er ikke blevet undersøgt tilstrækkeligt hos patienter, som har afbrudt tidligere behandling på grund af hæmatologiske uønskede hændelser.
The use of Pegasys and ribavirin combination therapy in chronic hepatitis C patients who failed prior treatment has not been adequately studied in patients who discontinued prior therapy for.
Nogle mennesker bliver deprimerede, når de anvender IntronA alene eller i kombinationsbehandling med ribavirin, og i nogle tilfælde fik mennesker tanker om at true andre mennesker på livet, selvmordstanker eller aggressiv opførsel sommetider rettet mod andre.
Some people get depressed when taking IntronA alone or in combination treatment with ribavirin, and in some cases people had thoughts about threatening the life of others, suicidal thoughts or aggressive behaviour sometimes directed against others.
Ved kombinationsbehandling med ribavirin, læs de tilsvarende oplysninger for lægemidler indeholdende ribavirin..
In combination therapy with ribavirin, take notice of the respective informing texts of ribavirin containing medicinal products.
Ribavirin kliniske undersøgelser hos voksne Anvendelsen af Ribavirin i kombinationsbehandling med peginterferon alfa- 2b eller interferon alfa- 2b blev vurderet i en række kliniske undersøgelser.
Ribavirin clinical trials in adults The use of Ribavirin in combination treatment with peginterferon alfa-2b or interferon alfa-2b was evaluated in a number of clinical trials.
I kombinationsbehandling med ribavirin, bemærk da de respektive informerende tekster vedrørende lægemidler indeholdende ribavirin..
In combination therapy with ribavirin, take notice of the respective informing texts of ribavirin containing medicinal products.
Resultater: 22,
Tid: 0.0306
Hvordan man bruger "ribavirin kombinationsbehandling" i en Dansk sætning
I tilfælde af leversvigt annulleres Algeron og Ribavirin kombinationsbehandling.
Derfor anbefales anvendelse af zidovudin sammen med dette lægemiddel og ribavirin-kombinationsbehandling ikke.
Derudover kan patienter behandlet med dette lægemiddel og ribavirin kombinationsbehandling og zidovudin have en øget risiko for at få anæmi (lavt antal røde blodlegemer).
Hvordan man bruger "ribavirin combination therapy" i en Engelsk sætning
Peginterferon alpha-2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose .
Two thirds (66%) of respondents currently used interferon and ribavirin combination therapy and a majority (59%) were using pegylated interferons.
"Outcomes of Peginterferon alfa-2a and Ribavirin Combination Therapy in" by Nicole M.
Pediatric subjects treated with PEGASYS plus ribavirin combination therapy showed a delay in weight and height increases up to 48 weeks of therapy compared with baseline.
Objectives: Despite this evidence, low dose ribavirin combination therapy has not been compared with peg interferon monotherapy in these patients so far.
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.
Common side effects of PEG-interferon-α and ribavirin combination therapy include fatigue, flu-like symptoms, hematological abnormalities, and neuropsychiatric symptoms.
The summary below is from the full report titled “Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C.
Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia.
Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
Ribavirin kombinationsbehandling
på forskellige sprog
English
Deutsch
Español
Suomi
Français
Norsk
عربى
Български
বাংলা
Český
Ελληνικά
עִברִית
हिंदी
Hrvatski
Magyar
Bahasa indonesia
Italiano
日本語
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
Svenska
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt
中文